Paloma Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$886K 731
2024
Q3
$886K Buy
1,000
+400
+67% +$360K 0.02% 447
2024
Q2
$543K Sell
600
-107
-15% -$85.6K 0.02% 708
2024
Q1
$550K Sell
707
-12,193
-95% -$8.68M 0.03% 407
2023
Q4
$7.52M Buy
+12,900
New +$7.53M 0.27% 56
2023
Q3
Sell
-11,700
Closed -$5.49M 839
2023
Q2
$5.49M Buy
+11,700
New +$4.91M 0.2% 90
2023
Q1
Sell
-3,900
Closed -$1.43M 882
2022
Q4
$1.43M Sell
3,900
-700
-15% -$248K 0.07% 284
2022
Q3
$1.49M Sell
4,600
-4,000
-47% -$1.27M 0.07% 234
2022
Q2
$2.79M Sell
8,600
-700
-8% -$210K 0.1% 198
2022
Q1
$2.66M Buy
9,300
+9,200
+9,200% +$2.37M 0.08% 178
2021
Q4
$28K Buy
+100
New +$25.4K ﹤0.01% 1847
2018
Q2
Sell
-38,500
Closed -$2.98M 1957
2018
Q1
$2.98M Sell
38,500
-32,000
-45% -$2.58M 0.05% 363
2017
Q4
$5.96M Buy
70,500
+21,500
+44% +$1.83M 0.08% 229
2017
Q3
$4.19M Hold
49,000
0.06% 341
2017
Q2
$4.03M Buy
49,000
+13,500
+38% +$1.1M 0.05% 395
2017
Q1
$2.99M Buy
35,500
+13,400
+61% +$1.07M 0.04% 553
2016
Q4
$1.63M Sell
22,100
-144,200
-87% -$10.7M 0.02% 824
2016
Q3
$13.3M Buy
166,300
+158,300
+1,979% +$12.7M 0.17% 81
2016
Q2
$630K Hold
8,000
0.01% 1427
2016
Q1
$576K Hold
8,000
0.01% 1231
2015
Q4
$674K Buy
+8,000
New +$664K 0.02% 863

Other funds holding LLY

Paloma Partners's LLY Position: Q3 2024 in Review

Paloma Partners sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 92 shares — an estimated $82.7K sold.

Paloma Partners first reported a position in LLY in Q2 2013 and held it in 34 quarters. The position peaked at $26.2M in Q3 2020. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Paloma Partners reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 92 Eli Lilly shares in Q3 2024, an estimated $82.7K.
  • Paloma Partners first reported a position in Eli Lilly in Q2 2013 and held it in 34 quarters.
  • Paloma Partners's Eli Lilly position peaked at $26.2M in Q3 2020.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.